Bioceramics Market Analysis By Material (Alumina, Zirconia), By Application (Dental, Orthopedic) And Segment Forecasts To 2022
Global bioceramics market is expected to reach USD 19.05 billion by 2022. Rising ageing population coupled with increasing occurrences of osteoarthritis is expected to augment market growth over the next seven years. Growing need to maintain a healthy lifestyle coupled with introduction of new low cost preventive care measures has led to the utilization of medical devices, which………..
Total Pages: 75
Bioceramics Market Overview
Global bioceramics sector is anticipated to get to USD 19.05 billion by 2022, according to a fresh report by Grand View Research, Inc. Increasing ageing populace in conjunction with rising incidences of osteoarthritis is anticipated to boost current market expansion within the subsequent seven years. Rising need to preserve healthy living along with launch of brand new inexpensive precautionary care and attention procedures has triggered the effective use of medical equipment, and that is likely to supplement growth of this marketplace.
Alumina ruled the worldwide industry, when it comes to materials, making up about 62% in 2014. Bioinertness, hardness and high abrasion resistance are a couple of its attributes, causing the substantial utilization of alumina implants for dental care and joint applications. Rising interest in biocompatible components to improve approval from the patients’ body along with minimizing the incidence of bacterial infections post surgical procedure is likely to supplement demand for alumina over the forecast period of time.
Global bioceramics market demand was USD 12.31 billion in 2014 and is estimated to attain USD 19.05 billion by 2022, rising with a CAGR of 6.2% from 2015 to 2022.
Bioceramics Market Trends
Growing ageing populace in developed economies is a significant element for optimistic development above the past several years and the tendency probably will continue in the future. Rising tendency of early surgical mediation by physicians in the event of joint replacements has triggered the demand from customers for knee, shoulder and hip implants. This can lead to growing market penetration of bioceramics within the orthopedic segment creating revenues worth USD 7.87 billion by 2022.
Breakthroughs in healthcare technologies and interest in advanced healthcare solutions & products are anticipated to enhance need for bioceramics within the forecast interval. Shifting food intake habits amongst youthful populace in conjunction with poor nutrition in diet plan have added to cavity formation and damaged tooth well being. This has resulted in improving demand for services of dental crowns, bridges, and bristles that has ultimately added in the direction of growing penetration of bioceramics in dental care.
The European union was the most significant market and it is anticipated to witness a CAGR of 5.7% from 2015 to 2022. Optimistic view towards orthopedic sector, primarily in Germany, is anticipated to push current market advancement.
Bioceramics Market Players
Key industry players including CeramTec, Amedica Corporation, Zimmer Biomet Holdings, Inc, DOCERAM Medical Ceramics GmbH, Straumann, Nobel Biocare and CoorsTek Medical, LLC. These companies are investing heavily in research and development activities of bioceramics materials. Companies such as CIRTEC Medical Systems perform thermal shock testing of brazed and ceramic components which help in making robust designs. In addition, the company is also using x-ray and dye penetration technology to evaluate various ceramic components.
Bioceramics Market Analysis - TOC
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Bioceramics market - Industry summary and key buying criteria, 2012-2022
Chapter 3. Bioceramics Industry Outlook
3.1. Bioceramics market segmentation
3.2. Bioceramics market size and growth prospects, 2012 - 2022
3.3. Bioceramics market - Value chain analysis
3.3.1. Vendor landscape
3.4. Raw material outlook
3.5. Technology overview
3.6. Regulatory framework
3.7. Bioceramics market dynamics
3.7.1. Market driver analysis
3.7.1.1. Aging demographics
3.7.1.2. Increasing trend of early surgical intervention
3.7.1.3. High penetration of implants
3.7.2. Market restraint analysis
3.7.2.1. Threat of substitutes
3.8. Market opportunities/potential
3.9. Key market opportunities – Prioritized
3.10. Bioceramics competitive landscape, 2014
3.11. Industry analysis - Porter's
3.12. Bioceramics market PESTEL analysis, 2014
Chapter 4. Bioceramics Material Outlook
4.1. Bioceramics market share by material, 2014 & 2022
4.2. Alumina
4.2.1. Bioceramics demand in alumina, 2012 - 2020
4.2.2. Bioceramics demand in alumina by region, 2012 - 2020
4.3. Zirconia
4.3.1. Bioceramics demand in zirconia, 2012 - 2020
4.3.2. Bioceramics demand in zirconia by region, 2012 - 2020
4.4. Others
4.4.1. Bioceramics demand in other material, 2012 - 2020
4.4.2. Bioceramics demand in other material by region, 2012 – 2020
Chapter 5. Bioceramics Market Application Outlook
5.1. Bioceramics market share by application, 2014 & 2022
5.2. Dental care
5.2.1. Bioceramics demand in agriculture, 2012 - 2022
5.2.2. Bioceramics demand in agriculture by region, 2012 – 2022
5.3. Orthopedic
5.3.1. Bioceramics demand in agriculture, 2012 - 2022
5.3.2. Bioceramics demand in agriculture by region, 2012 - 2022
5.4. Others
5.4.1. Bioceramics demand in agriculture, 2012 - 2022
5.4.2. Bioceramics demand in agriculture by region, 2012 - 2022
Chapter 6. Bioceramics Regional Outlook
6.1. Global bioceramics market share by region, 2014 & 2022
6.2. North America
6.2.1. Market estimates and forecast, 2012 – 2022
6.2.2. Market estimates and forecast by material, 2012-2022
6.2.3. Market estimates and forecast by application, 2012-2022
6.2.4. U.S.
6.2.4.1. Market estimates and forecast by material, 2012-2022
6.2.4.2. Market estimates and forecast by application, 2012-2022
6.3. Europe
6.3.1. Market estimates and forecast, 2012 – 2022
6.3.2. Market estimates and forecast by material, 2012-2022
6.3.3. Market estimates and forecast by application, 2012-2022
6.3.4. Germany
6.3.4.1. Market estimates and forecast by material, 2012-2022
6.3.4.2. Market estimates and forecast by application, 2012-2022
6.4. Asia Pacific
6.4.1. Market estimates and forecast, 2012 – 2022
6.4.2. Market estimates and forecast by material, 2012-2022
6.4.3. Market estimates and forecast by application, 2012-2022
6.4.4. Japan
6.4.4.1. Market estimates and forecast, 2012 – 2022
6.4.4.2. Market estimates and forecast by material, 2012-2022
6.4.4.3. Market estimates and forecast by application, 2012-2022
6.4.5. China
6.4.5.1. Market estimates and forecast, 2012 – 2022
6.4.5.2. Market estimates and forecast by material, 2012-2022
6.4.5.3. Market estimates and forecast by application, 2012-2022
6.5. RoW
6.5.1. Market estimates and forecast, 2012 – 2022
6.5.2. Market estimates and forecast by material, 2012-2022
6.5.3. Market estimates and forecast by application, 2012-2022
Chapter 7. Competitive Landscape
7.1. Wright Medical Group, Inc
7.1.1. Company Overview
7.1.2. Financial Performance
7.1.3. Product Benchmarking
7.1.4. Strategic Initiatives
7.2. Royal DSM
7.2.1. Company Overview
7.2.2. Financial Performance
7.2.3. Product Benchmarking
7.2.4. Strategic Initiatives
7.3. Zimmer Biomet Holdings, Inc
7.3.1. Company Overview
7.3.2. Financial Performance
7.3.3. Product Benchmarking
7.3.4. Strategic Initiatives
7.4. CeramTec
7.4.1. Company Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Strategic Initiatives
7.5. Amedica Corporation
7.5.1. Company Overview
7.5.2. Financial Performance
7.5.3. Product Benchmarking
7.5.4. Strategic Initiatives
7.6. CAM Bioceramics BV
7.6.1. Company Overview
7.6.2. Financial Performance
7.6.3. Product Benchmarking
7.6.4. Strategic Initiatives
7.7. Berkeley Advanced Biomaterials, Inc
7.7.1. Company Overview
7.7.2. Financial Performance
7.7.3. Product Benchmarking
7.7.4. Strategic Initiatives
7.8. Straumann
7.8.1. Company Overview
7.8.2. Financial Performance
7.8.3. Product Benchmarking
7.8.4. Strategic Initiatives
7.9. Nobel Biocare
7.9.1. Company Overview
7.9.2. Financial Performance
7.9.3. Product Benchmarking
7.9.4. Strategic Initiatives
7.10. Collagen Matrix, Inc
7.10.1. Company Overview
7.10.2. Financial Performance
7.10.3. Product Benchmarking
7.10.4. Strategic Initiatives
7.11. Morgan Technical Ceramics
7.11.1. Company Overview
7.11.2. Financial Performance
7.11.3. Product Benchmarking
7.11.4. Strategic Initiatives
7.12. Kyocera Corporation
7.12.1. Company Overview
7.12.2. Financial Performance
7.12.3. Product Benchmarking
7.12.4. Strategic Initiatives
7.13. DOCERAM Medical Ceramics GmbH
7.13.1. Company Overview
7.13.2. Financial Performance
7.13.3. Product Benchmarking
7.13.4. Strategic Initiatives
7.14. Dentsply International
7.14.1. Company Overview
7.14.2. Financial Performance
7.14.3. Product Benchmarking
7.14.4. Strategic Initiatives
7.15. Smith & Nephew plc
7.15.1. Company Overview
7.15.2. Financial Performance
7.15.3. Product Benchmarking
7.15.4. Strategic Initiatives
7.16. CIRTEC Medical Systems
7.16.1. Company Overview
7.16.2. Financial Performance
7.16.3. Product Benchmarking
7.16.4. Strategic Initiatives
7.17. CoorsTek Medical
7.17.1. Company Overview
7.17.2. Financial Performance
7.17.3. Product Benchmarking
7.17.4. Strategic Initiatives
7.18. DePuy Synthes
7.18.1. Company Overview
7.18.2. Financial Performance
7.18.3. Product Benchmarking
7.18.4. Strategic Initiatives
7.19. Stryker Corporation
7.19.1. Company Overview
7.19.2. Financial Performance
7.19.3. Product Benchmarking
7.19.4. Strategic Initiatives
7.20. Tosoh Corporation
7.20.1. Company Overview
7.20.2. Financial Performance
7.20.3. Product Benchmarking
7.20.4. Strategic Initiatives
